Obstetrics & Gynecology Doctors in Lafayette, CA Accepting Medicare

4 Obstetrics & Gynecology doctors found. Showing 1 - 4

Dr. Andrea Mendelssohn, MD, FACOG, FABIHM Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 970 Dewing Ave Ste 203, Lafayette, CA 94549 Phone: 925-299-9001    Fax: 925-299-9018

Nancy H Wigginton, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3687 Mt Diablo Blvd Ste 200, Lafayette, CA 94549 Phone: 510-204-6660

Dr. Anahat Kaur Sandhu, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 970 Dewing Ave Ste 203, Lafayette, CA 94549 Phone: 925-299-9001    Fax: 925-299-9018

Ms. Karen Lee Kashkin, MD Obstetrics & Gynecology - Gynecology Medicare: Not Enrolled in Medicare Practice Location: 911 Moraga Rd, Ste 201, Lafayette, CA 94549 Phone: 925-284-3040    Fax: 925-283-6087

News Archive

Pro-Pharmaceuticals, Mount Sinai collaborate to evaluate anti-fibrotic effects of Galectin-targeting compounds

Pro-Pharmaceuticals, Inc., the leading developer of Galectin therapeutics to treat cancer and fibrosis, today announced it has entered into a new research collaboration with Mount Sinai School of Medicine to evaluate in pre-clinical models, the anti-fibrotic effects of several of the Company's novel, Galectin-targeting compounds.

New immunotherapy sends multiple myeloma into remission

Researchers are reporting the impressive results of a new cell and gene therapy that has achieved unprecedented success in treating multiple myeloma patients. Although the study is an early one and the population only included 35 people, every one of the patients responded to the treatment and 33 (94%) were in some degree of clinical remission within two months.

New whitepaper examines main strategies employed to optimise target enrichment for NGS assays

Oxford Gene Technology, provider of innovative genetics research and biomarker solutions to advance molecular medicine, has produced a free whitepaper titled ‘The importance of enrichment assay choice and optimisation for confident variant detection.' The paper investigates the main strategies employed to optimise target enrichment for next generation sequencing assays, assisting researchers to make informed decisions when designing studies.

Melior Discovery, Rett Syndrome Research Trust collaborate to screen drug-candidates

Melior Discovery, Inc. announced today that it has entered into collaboration with the Rett Syndrome Research Trust to screen drug-candidates in an in vivo model of Rett Syndrome.

Ethnicity strongly linked to treatment resistance in schizophrenia

Patients with schizophrenia are at heightened risk for being resistant to treatment if they are White European, study findings reveal.

Read more Medical News

› Verified 7 days ago